Dong-A Pharmaceutical Co.,Ltd. Q3 operating profit KRW 35.1 billion, up 5.4% from a year earlier
AI summary · Not investment advice
In Q3, the company sold KRW 431.0 billion and earned KRW 35.1 billion from its main business, up 5.4% from a year earlier and down 9.9% from the prior quarter.
Operating profit · 3 months
KRW 35.1 billion
Key facts
- Revenue (3 months)
- KRW 431.0 billion
- Net income (3 months)
- KRW 32.1 billion
- Period
- Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
- Revenue (prior-year 3 months)
- KRW 382.6 billion
- Revenue (year to date)
- KRW 1.2 trillion
- Operating profit (prior-year 3 months)
- KRW 33.3 billion
- Operating profit (year to date)
- KRW 93.2 billion
- Net income (prior-year 3 months)
- KRW 47.1 billion
- Net income (year to date)
- KRW 81.5 billion
Commentary
AI commentary · Not investment advice
What happened
Dong-A Pharmaceutical filed its quarterly report for the third quarter on a consolidated basis. Sales for the latest 3 months were KRW 431.04 billion. That is 12.7% higher than the same 3 months a year earlier and 4.5% higher than the previous quarter.
In the company's terms
Operating profit (money earned from the core business) for the 3 months was KRW 35.10 billion. It rose 5.4% from a year earlier and fell 9.9% from the previous quarter.
What changes for shareholders
Net income (the final profit left after taxes and other costs) for the 3 months was KRW 32.13 billion. It fell 31.8% from a year earlier and rose 11.2% from the previous quarter.
For January through September combined, sales were KRW 1,194.43 billion. Operating profit was KRW 93.19 billion and net income was KRW 81.53 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
D